Ignite Creation Date:
2025-12-25 @ 4:04 AM
Ignite Modification Date:
2026-03-14 @ 9:44 AM
Study NCT ID:
NCT04260802
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-12-23
First Post:
2020-02-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers
Sponsor:
Ocellaris Pharma, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Cancer | View |
| None | Neoplasms | View |
| None | Metastatic Cancer | View |
| None | Triple Negative Breast Cancer | View |
| None | Gastric Cancer | View |
| None | Cervical Cancer | View |
| None | Ovarian Cancer | View |
| None | Hepatocellular Carcinoma | View |
| None | Squamous Cell Carcinoma of Head and Neck | View |
| None | Urothelial Carcinoma | View |
| None | Urothelial Neoplasm | View |
| None | Non Small Cell Lung Cancer | View |
| None | Renal Cell Carcinoma | View |
| None | Locally Advanced Solid Tumor | View |
| None | Locally Advanced Malignant Neoplasm | View |
| None | Squamous Cell Carcinoma | View |
| None | Sarcoma | View |
| None | Merkel Cell Carcinoma | View |
| None | Bladder Cancer | View |
Keywords: